Explore the words cloud of the TRANSVAC2 project. It provides you a very rough idea of what is the project "TRANSVAC2" about.
The following table provides information about the project.
EUROPEAN VACCINE INITIATIVE EWIV
|Coordinator Country||Germany [DE]|
|Total cost||10˙599˙993 €|
|EC max contribution||10˙599˙993 € (100%)|
1. H2020-EU.18.104.22.168. (Integrating and opening existing national and regional research infrastructures of European interest)
|Duration (year-month-day)||from 2017-05-01 to 2022-04-30|
Take a look of project's partnership.
|1||EUROPEAN VACCINE INITIATIVE EWIV||DE (HEIDELBERG)||coordinator||1˙254˙147.00|
|2||UNIVERSITA DEGLI STUDI DI SIENA||IT (SIENA)||participant||706˙430.00|
|3||VACCINE FORMULATION INSTITUTE LIMITED||UK (GODALMING)||participant||670˙975.00|
|4||COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES||FR (PARIS 15)||participant||669˙527.00|
|5||THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD||UK (OXFORD)||participant||640˙594.00|
|6||STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER||NL (RIJSWIJK ZH)||participant||626˙813.00|
|7||STATENS SERUM INSTITUT||DK (KOBENHAVN S)||participant||601˙445.00|
|8||INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA||PT (OEIRAS)||participant||595˙332.00|
|9||INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES||ES (CALDES DE MONTBUI BARCELONA)||participant||587˙866.00|
|10||ACADEMISCH ZIEKENHUIS LEIDEN||NL (LEIDEN)||participant||555˙000.00|
|11||FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.||DE (MUNCHEN)||participant||490˙307.00|
|12||STICHTING WAGENINGEN RESEARCH||NL (WAGENINGEN)||participant||471˙015.00|
|13||HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH||DE (BRAUNSCHWEIG)||participant||402˙090.00|
|14||Department of Health||UK (Leeds)||participant||384˙120.00|
|15||MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT||NL (DEN HAAG)||participant||334˙975.00|
|16||EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH||CH (ZUERICH)||participant||288˙000.00|
|17||ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK||FR (PARIS)||participant||226˙750.00|
|18||UNIVERSITEIT LEIDEN||NL (LEIDEN)||participant||212˙050.00|
|19||EATRIS ERIC||NL (AMSTERDAM)||participant||211˙831.00|
|20||INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT||FR (PARIS CEDEX 07)||participant||202˙283.00|
|21||LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER||UK (LONDON)||participant||130˙832.00|
|22||BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE||FR (LYON)||participant||124˙031.00|
|23||GENIBET - BIOPHARMACEUTICALS SA||PT (OEIRAS)||participant||108˙992.00|
|24||SCLAVO VACCINES ASSOCIATION||IT (SIENA)||participant||75˙320.00|
|25||INSTRUCT ACADEMIC SERVICES LIMITED||UK (OXFORD)||participant||29˙260.00|
|26||UNIVERSITE DE LAUSANNE||CH (LAUSANNE)||participant||0.00|
TRANSVAC2 is the follow-up project to its successful predecessor project TRANSVAC, the European Network of Vaccine Research and Development funded under FP7. The TRANSVAC2 consortium comprises a comprehensive collection of leading European institutions that propose to further advance with the previous initiative towards the establishment of a fully operational and sustainable European vaccine R&D infrastructure. TRANSVAC2 will support innovation for both prophylactic and therapeutic vaccine development based on a disease-overarching and one-health approach, thereby optimising the knowledge and expertise gained during the development of both human and animal vaccines. This will be achieved by bridging the translational gap in biomedical research, and by supporting cooperation between public vaccine R&D institutions of excellence, related initiatives and networks in Europe, and industrial partners. TRANSVAC2 will complement and integrate with existing European research infrastructures in both the public and private sectors. TRANSVAC2 will function as leverage and innovation catalyst between all stakeholders involved in vaccine R&D in Europe and -by providing integrated and overarching vaccine R&D services- will contribute to the development of effective products to address European and global health challenges, to controlling the burden and spread of infectious diseases, and reinforce the economic assets represented by vaccine developers in Europe. The impact of TRANSVAC2 will be maximised by two external advisory bodies. An independent Scientific & Ethics Advisory Committee will provide recommendations surrounding scientific-technical and ethical issues, whereas the coordination of TRANSVAC2 with other related initiatives and the further promotion of the long-term stability of a European vaccine R&D infrastructure will be supported by a Board of Stakeholders comprising representatives of policy and decision makers, industry associations and European infrastructures.
|Standardised assays for the characterisation of immune sera by calibration-free concentration analysis||Other||2020-02-25 15:31:00|
|Programme for customised training courses||Other||2020-02-25 15:31:00|
|Launch of TRANSVAC2 web site||Websites, patent fillings, videos etc.||2020-02-25 15:31:01|
|Contact with five external projects and initiatives||Other||2020-02-25 15:31:00|
|Detailed description of the infrastructure for the TRANSVAC2 web site||Documents, reports||2020-02-25 15:31:01|
|Standardised assays for the functional characterisation of vaccine candidates using monoclonal antibodies and/or ligand interactions||Other||2020-02-25 15:31:00|
|Establishment of Board of Stakeholders||Other||2020-02-25 15:31:01|
|Appointment of all SEAC members||Other||2020-02-25 15:31:01|
Take a look to the deliverables list in detail: detailed list of TRANSVAC2 deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRANSVAC2" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TRANSVAC2" are provided by the European Opendata Portal: CORDIS opendata.
Network of Leading Ecosystem Scale Experimental AQUAtic MesoCOSM Facilities Connecting Rivers, Lakes, Estuaries and Oceans in Europe and beyondRead More
Solar Facilities for the European Research Area - Third PhaseRead More
Enabling Science and Technology through European Electron MicroscopyRead More